April 2026 SOP Tracker Update: Pharmacists Are Being Recognized as Part of the Care Gap Solution

Across the country, health care access is becoming one of the defining issues for patients, payers, employers, and policymakers.

Patients are waiting longer for care. Primary care access remains strained. Rural communities continue to face provider shortages. Preventive services are still underutilized. And at the same time, pharmacies remain one of the most accessible health care destinations in nearly every community.

That is why pharmacist scope of practice legislation matters.

For years, pharmacists have been positioned as one of the most underused clinical resources in the health care system. They are highly trained, widely accessible, and already embedded in the daily health decisions of patients. But historically, state laws and payer reimbursement structures have not always kept up with what pharmacists are capable of doing.

That is beginning to change.

Each month, Provider CSAO will use our SOP Tracker updates to highlight some of the most important legislative movements impacting clinical pharmacy. Our goal is not just to report what passed or moved forward. Our goal is to explain why it matters, what it could mean for pharmacists, and how these changes may shape the future of pharmacy-based clinical care.

For April 2026, two states stood out: Kentucky and Colorado. Kentucky HB 3: Medicaid reimbursement for pharmacist services becomes law

Kentucky delivered one of the most important pharmacist reimbursement updates of the month.

HB 3 was signed by the Governor on April 13, 2026, becoming Acts Chapter 99. The bill relates to reimbursement for pharmacist services and requires Medicaid and KCHIP to comply with pharmacy reimbursement requirements for pharmacist services. It also directs the state to seek federal approval if needed.

This is significant because Kentucky has already been one of the most important states to watch in the pharmacist provider movement.

Kentucky has built strong momentum around pharmacist provider status and payment parity. HB 3 now brings Medicaid and KCHIP further into that framework. That matters because Medicaid patients often face some of the greatest care access challenges, and pharmacies are frequently one of the most reachable health care access points for these communities.

For Kentucky pharmacists, this law creates a clearer statutory foundation for Medicaid reimbursement of pharmacist-provided services.

That does not mean every payer, operational, credentialing, and billing question is solved overnight. Implementation still matters. Medicaid programs and MCOs will still need processes, contracts, credentialing pathways, billing rules, and claims infrastructure that allow pharmacists to actually participate.

But HB 3 gives Kentucky pharmacists something extremely important: a stronger legal and reimbursement framework to build from.

This is how clinical pharmacy moves from concept to infrastructure.

Colorado HB26-1336: Moving toward coverage for pharmacist-provided services

Colorado’s HB26-1336, the Increase Access to Pharmacy Services bill, made meaningful progress in April. The bill passed the House on April 21 and advanced out of the Senate Health & Human Services Committee on April 30.

The core importance of this bill is that it does not stop at scope of practice. It moves into coverage and reimbursement.

HB26-1336 would allow health benefit plans to cover health care services provided by pharmacists when those services are within the pharmacist’s scope of practice and certain requirements outlined in collaborative practice agreements are met. The bill also addresses Medicaid reimbursement alignment with pharmacist scope of practice, expands certain prescriptive authority, and includes pharmacy practice modernization components.

That is a big deal.

Too often, pharmacist scope of practice laws answer only the first question: “Is the pharmacist allowed to provide the service?”

But the next question is just as important: “Will the pharmacist be recognized and reimbursed for providing it?”

Colorado is moving toward answering both.

For Colorado pharmacists, this bill could create a stronger foundation for clinical service delivery across commercial plans and Medicaid. It supports the idea that if a pharmacist is legally allowed and clinically trained to provide a service, payers should not be able to ignore that service simply because it was performed by a pharmacist.

That distinction matters for independent pharmacies, health-system pharmacies, rural pharmacies, and any organization trying to build sustainable clinical programs.

The future of pharmacy cannot rely solely on product reimbursement. Pharmacists need a pathway to be paid for clinical care. Colorado HB26-1336 is an important step in that direction.

Why these updates matter nationally

Colorado and Kentucky are two different stories, but they point toward the same future.

Colorado is moving legislation that connects pharmacist scope of practice with health plan coverage. Kentucky has enacted legislation that strengthens Medicaid and KCHIP reimbursement pathways for pharmacist services.

Both updates reflect the same larger trend: states are beginning to recognize that pharmacists are not just medication dispensers. They are clinical access points.

That recognition is important because the health care system needs more accessible care models. Pharmacists can support immunizations, preventive care, chronic disease management, medication optimization, public health initiatives, and other services that help close gaps before patients end up in higher-cost settings.

But for pharmacists to do that work at scale, the system has to support them.

That means scope of practice.

It also means credentialing.

It means payer contracting.

It means medical billing pathways.

It means reimbursement.

And it means recognizing pharmacists as part of the health care delivery network, not as an afterthought or dispensing intermediary.

At Provider CSAO, this is exactly why we track these changes so closely. Legislative momentum is not just policy news. It is market movement. It tells us where clinical pharmacy is heading, where payer conversations may evolve, and where pharmacies should begin preparing for the next stage of care delivery.

April was a strong month for that momentum.

Colorado showed us what it looks like when coverage and pharmacist scope begin to align.

Kentucky showed us what it looks like when Medicaid reimbursement for pharmacist services becomes part of the statutory framework.

Both are signs of a profession moving forward. If you have questions about your states SOP Legislation, check out our free tracker here:

Provider CSAO: SOP Legislation Tracker

April State Advancements

State	April 2026 update	Bill / topic	Why it matters
Colorado	Passed House April 21; advanced out of Senate Health & Human Services April 30	HB26-1336, Increase Access to Pharmacy Services	Would require coverage for pharmacist services within scope, authorize Medicaid reimbursement for pharmacist services, prohibit certain discrimination against pharmacist participation, and expand pharmacist prescriptive authority for certain patients age 5 to 11.
Connecticut	Signed in late April	Vaccine access legislation	Protects pharmacist vaccine authority, separates state vaccine standards from federal ACIP dependency, requires state-regulated insurance coverage, and creates an adult flu vaccine pilot.
Georgia	Sent to Governor April 10	SB 195, pharmacist PrEP/PEP authority	Authorizes pharmacists to dispense HIV PrEP and PEP under defined conditions and Board of Pharmacy training requirements.
Hawaii	Active conference movement throughout April; conference action April 30	HB 1898, clinical preventive services / vaccines	Would address DOH preventive service recommendations, standing orders, insurance coverage, and allow registered pharmacists to order vaccines based on DOH recommendations.
Kansas	Signed by Governor April 9	HB 2068, Pharmacy Practice Act changes	Expands pharmacy practice provisions including remote practice, pharmacist initiation of therapy, emergency refills up to 90 days, compounding standards, and PDMP access/delegation updates.
Kentucky	Signed by Governor April 13	HB 3, pharmacist services reimbursement	Requires Medicaid and KCHIP to comply with pharmacy reimbursement requirements for pharmacist services and seek federal approval if needed.
Maryland	Approved April 14	SB 385 / HB 637, Vax Act	Alters pharmacist vaccination authority and connects immunization, screening, and preventive service recommendations with insurance coverage requirements.
Maryland	Approved April 28	HB 1135 / SB 773, pharmacist vaccination orders	Allows pharmacists to order certain vaccinations for individuals at least 3 years old without also administering the vaccination themselves.
Missouri	Referred to House Health & Mental Health Committee April 23; executive session April 30	SB 878, pharmacist duties / medical devices	Would authorize pharmacists to prescribe certain medical devices, with rules to be jointly promulgated by the Board of Pharmacy and Board of Healing Arts.
New Hampshire	Engrossed April 2; Senate hearing April 9	HB 1249, pharmacist prescribing of medical devices	Would authorize pharmacists to prescribe certain prescription devices needed for drug delivery or administration, including spacers, nebulizers, diabetes testing supplies, pen needles, and related supplies.
Tennessee	Passed Senate April 20 and House April 21; sent to Governor	SB 2040 / HB 1959, PBM reform	Major PBM reform package; implementation was amended to July 1, 2028.
Virginia	Approved April 6; effective July 1, 2026	SB 421, remote pharmacy practice in opioid treatment programs	Allows remote pharmacist verification, counseling, and supervision duties when authorized personnel dispense opioid use disorder medications at federally certified opioid treatment programs.
Virginia	Approved April 6	SB 379, psilocybin scheduling / Board of Pharmacy	Directs Board of Pharmacy treatment of psilocybin scheduling if federal and FDA conditions are met.